Clincosm LogoSign in Get a demo

ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES

Sponsor
University of Minnesota (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05628194
Collaborator
(none)
5,000
Enrollment
1
Location
5
Anticipated Duration (Months)
1007.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to describe current knowledge and opinions about anal cancer screening among men who have sex with men (MSM), as well as their experience receiving guideline-compliant care aimed at anal cancer risk reduction using a large-scale survey disseminated via social media.

Condition or Disease Intervention/Treatment Phase
  • Other: Observational/Survery

Study Design

Study Type:
Observational
Anticipated Enrollment :
5000 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
SAVE THE BOTTOMS!!!: ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Men who have sex with men (MSM)

Other: Observational/Survery
MSM participants will complete a one-time survey, delivered in an e-format. Survey will be accessible via Meta-based social media platforms (Facebook, Instagram).

Outcome Measures

Primary Outcome Measures

  1. MSM awareness of anal cancer risk [2 months]

    Survey with question items on participants' awareness of anal cancer risk

  2. MSM awareness of strategies to decrease anal cancer risk [2 months]

    Survey with question items of strategies to decrease anal cancer risk

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • ≥18 years of age

  • Current resident of the U.S.

  • Engage in anoreceptive intercourse with male partners

  • Fluent in English or Spanish

Exclusion Criteria:

  • Under the age of 18 years old

  • Not living in the United States

  • Not born with sex assigned at birth as male

  • Does not engage in sex with male partners

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Minnesota Minneapolis Minnesota United States 55455

Sponsors and Collaborators

  • University of Minnesota

Investigators

  • Principal Investigator: Elliot Arsoniadis, M.D., Ph.D, University of Minnesota

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT05628194
Other Study ID Numbers:
  • HRP-580
First Posted:
Nov 28, 2022
Last Update Posted:
Nov 28, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Anus Neoplasms

Study Results

No Results Posted as of Nov 28, 2022